Migraine clinical trials in Florida
12 studies for Migraine are looking for participants at sites in Florida.
Cities in Florida
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Direct Helpers Research Center, Hialeah
- D&H Tamarac Research Center LLC, Tamarac
- Santos Research Center, CORP, Tampa
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 28, 2026 · NCT05156398Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- South Florida Research Phase I-IV, Inc, Miami
- Aqualane Clinical Research, Naples
- Clinical Associates of Orlando, LLC, Orlando
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 24, 2026 · NCT04649242Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- South Florida Research Phase I-IV, Inc, Miami
- Clinical Associates of Orlando, LLC, Orlando
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 24, 2026 · NCT04743141A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Northwest Florida Clinical Research Group, LLC /ID# 270833, Gulf Breeze
- My Preferred Research /ID# 270312, Miami
- Encore Medical Research - Weston /ID# 271139, Weston
- and 1 more
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Sep 22, 2026 · NCT06810505Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Memorial Healthcare, Hollywood
- Mayo Clinic Florida, Jacksonville
- Apple Med Research, Miami
- and 1 more
RecruitingPhase 4
Ages 18 to 70 · All sexes · Updated Sep 16, 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Encore Medical Research of Boynton Beach LLC /ID# 246833, Boynton Beach
- Gulf Coast Clinical Research Center /ID# 230020, Fort Myers
- AGA Clinical Trials /ID# 230554, Hialeah
- and 9 more
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 14, 2026 · NCT05125302Study of EVO756 in Adults With Migraine
- Clinical Neuroscience Solutions, Inc., Jacksonville
- Apple Medical Research Group, Inc, Miami
- Blessed Healthcase & Research, Miami
- and 4 more
RecruitingPhase 2
Ages 18 to 64 · All sexes · Updated Sep 3, 2026 · NCT07616128Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
- Clinical Neuroscineces Solutions - Orlando, Orlando
- Clinical Neuroscineces Solutions, Orlando
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 2, 2026 · NCT07646613A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- NW FL Clinical Research Group, LLC, Gulf Breeze
- AGA Clinical Trials - Hialeah - 4980 W 10th Ave, Hialeah
- University of South Florida, Tampa
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Jun 12, 2026 · NCT05164172A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
- Homestead Associates in Research, Inc., Homestead
- Florida Neurology - Lake Mary, Lake Mary
- Flourish Research - Miami, LLC dba Flourish Research, Miami
- and 2 more
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated May 19, 2026 · NCT06602479Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine
- University of Miami, Miller School of Medicine, Miami
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 8, 2025 · NCT07159750Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
- Upsher-Smith Clinical Trial Site #14, Tampa
RecruitingPhase 4
Ages 6 to 11 · All sexes · Updated Jan 27, 2025 · NCT04748601From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.